Céline Moison, Ph.D.

Céline obtained her Ph.D. in Genetics from the University Paris 6, France. In collaboration with Pierre Fabre Pharmaceutics, she studied epigenetics and the mechanisms involved in tumor suppressor gene silencing in breast and prostate cancers. In 2013, she joined Dr. Guy Sauvageau’s lab as a Postoctoral Fellow and now leads the chemo-genomic group of the Leucegene project, which aims to find alternative therapeutic options for poor-prognosis subtypes of AML.